International Journal of Inflammation / 2013 / Article / Tab 2

Clinical Study

Cost Effectiveness of TNF- Inhibitors in Rheumatoid Arthritis

Table 2

Analysis of SF-36 scores.

SF-36 domainPhaseDifference in mean (%)P value*

Physical function (PF)Phase 1-Phase 236.540.00
Phase 1-Phase 338.460.00
Phase 2-Phase 31.920.96

Physical role (PR)Phase 1-Phase 269.230.00
Phase 1-Phase 373.080.00
Phase 2-Phase 33.850.94

Emotional role (ER)Phase 1-Phase 264.070.00
Phase 1-Phase 379.460.00
Phase 2-Phase 315.400.20

Bodily pain (BP)
Phase 1-Phase 251.620.00
Phase 1-Phase 358.620.00
Phase 2-Phase 37.000.48

Vitality (V)Phase 1-Phase 241.920.00
Phase 1-Phase 344.230.00
Phase 2-Phase 32.310.85

Social functioning (SF)Phase 1-Phase 254.810.00
Phase 1-Phase 356.730.00
Phase 2-Phase 31.920.93

Mental health (MH)Phase 1-Phase 232.620.00
Phase 1-Phase 334.150.00
Phase 2-Phase 31.540.97

General health (GH)Phase 1-Phase 225.080.00
Phase 1-Phase 326.850.00
Phase 2-Phase 31.770.90

The difference in mean scores obtained between phases for every SF-36 domain and their relative level of significance (significance noted at *).

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.